These studies report different effects of total, LDL, and HDL-cholesterol on cancer incidence, the magnitude of which can be influenced by variables such as estrogen receptor (ER) and menopausal status, disease subtype, and comorbid inflammatory conditions3–6. Here, ESR1 is linked to cancer.